148 related articles for article (PubMed ID: 21264544)
1. RRP22: a novel neural tumor suppressor for astrocytoma.
Chen R; Yang L; Fang J; Huo L; Zhang M; Chen F; Liu J; Wu J; Wang Y
Med Oncol; 2012 Mar; 29(1):332-9. PubMed ID: 21264544
[TBL] [Abstract][Full Text] [Related]
2. DLC2/StarD13 plays a role of a tumor suppressor in astrocytoma.
El-Sitt S; Khalil BD; Hanna S; El-Sabban M; Fakhreddine N; El-Sibai M
Oncol Rep; 2012 Aug; 28(2):511-8. PubMed ID: 22614672
[TBL] [Abstract][Full Text] [Related]
3. DNA hypermethylation and histone modifications downregulate the candidate tumor suppressor gene RRP22 on 22q12 in human gliomas.
Schmidt N; Windmann S; Reifenberger G; Riemenschneider MJ
Brain Pathol; 2012 Jan; 22(1):17-25. PubMed ID: 21631628
[TBL] [Abstract][Full Text] [Related]
4. RRP22 is a farnesylated, nucleolar, Ras-related protein with tumor suppressor potential.
Elam C; Hesson L; Vos MD; Eckfeld K; Ellis CA; Bell A; Krex D; Birrer MJ; Latif F; Clark GJ
Cancer Res; 2005 Apr; 65(8):3117-25. PubMed ID: 15833841
[TBL] [Abstract][Full Text] [Related]
5. EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas.
Tsai WC; Chen Y; Huang LC; Lee HS; Ma HI; Huang SM; Sytwu HK; Hueng DY
J Neurooncol; 2013 Sep; 114(3):281-90. PubMed ID: 23817808
[TBL] [Abstract][Full Text] [Related]
6. NPAS3 demonstrates features of a tumor suppressive role in driving the progression of Astrocytomas.
Moreira F; Kiehl TR; So K; Ajeawung NF; Honculada C; Gould P; Pieper RO; Kamnasaran D
Am J Pathol; 2011 Jul; 179(1):462-76. PubMed ID: 21703424
[TBL] [Abstract][Full Text] [Related]
7. Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma.
Jiang Z; Li X; Hu J; Zhou W; Jiang Y; Li G; Lu D
Neurosci Res; 2006 Dec; 56(4):450-8. PubMed ID: 17049657
[TBL] [Abstract][Full Text] [Related]
8. Expression and prognostic value of NDRG2 in human astrocytomas.
Li L; Wang J; Shen X; Wang L; Li X; Liu Y; Shi M; Zhao G; Deng Y
J Neurol Sci; 2011 Sep; 308(1-2):77-82. PubMed ID: 21705028
[TBL] [Abstract][Full Text] [Related]
9. Reduced TSC2 RNA and protein in sporadic astrocytomas and ependymomas.
Wienecke R; Guha A; Maize JC; Heideman RL; DeClue JE; Gutmann DH
Ann Neurol; 1997 Aug; 42(2):230-5. PubMed ID: 9266734
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of the tumor suppressor A-kinase anchor protein 12 in human diffuse and pilocytic astrocytomas is regulated by promoter methylation.
Goeppert B; Schmidt CR; Geiselhart L; Dutruel C; Capper D; Renner M; Vogel MN; Zachskorn C; Zinke J; Campos B; Schmezer P; Popanda O; Wick W; Weller M; Meyermann R; Schittenhelm J; Harter PN; Simon P; Weichert W; Schirmacher P; Plass C; Mittelbronn M
J Neuropathol Exp Neurol; 2013 Oct; 72(10):933-41. PubMed ID: 24042196
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of the RNA-binding motif protein 3 in human astrocytoma.
Zhang HT; Zhang ZW; Xue JH; Kong HB; Liu AJ; Li SC; Liu YX; Xu DG
Chin Med J (Engl); 2013; 126(10):1948-52. PubMed ID: 23673116
[TBL] [Abstract][Full Text] [Related]
12. Promoter hypermethylation-mediated down-regulation of CXCL12 in human astrocytoma.
Zhou W; Jiang Z; Song X; Liu Y; Wen P; Guo Y; Xu F; Kong L; Zhang P; Han A; Yu J
J Neurosci Res; 2008 Oct; 86(13):3002-10. PubMed ID: 18512766
[TBL] [Abstract][Full Text] [Related]
13. High expression of Aurora-B/Aurora and Ipll-like midbody-associated protein (AIM-1) in astrocytomas.
Araki K; Nozaki K; Ueba T; Tatsuka M; Hashimoto N
J Neurooncol; 2004; 67(1-2):53-64. PubMed ID: 15072448
[TBL] [Abstract][Full Text] [Related]
14. High CHI3L1 expression is associated with glioma patient survival.
Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
[TBL] [Abstract][Full Text] [Related]
15. Tissue thioredoxin reductase-1 expression in astrocytomas of different grades.
Esen H; Erdi F; Kaya B; Feyzioglu B; Keskin F; Demir LS
J Neurooncol; 2015 Feb; 121(3):451-8. PubMed ID: 25391969
[TBL] [Abstract][Full Text] [Related]
16. Galectins are differentially expressed in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas, and significantly modulate tumor astrocyte migration.
Camby I; Belot N; Rorive S; Lefranc F; Maurage CA; Lahm H; Kaltner H; Hadari Y; Ruchoux MM; Brotchi J; Zick Y; Salmon I; Gabius HJ; Kiss R
Brain Pathol; 2001 Jan; 11(1):12-26. PubMed ID: 11145198
[TBL] [Abstract][Full Text] [Related]
17. Metallothionein Genes are Highly Expressed in Malignant Astrocytomas and Associated with Patient Survival.
Masiulionytė B; Valiulytė I; Tamašauskas A; Skiriutė D
Sci Rep; 2019 Apr; 9(1):5406. PubMed ID: 30932010
[TBL] [Abstract][Full Text] [Related]
18. Reduced expression of PDCD5 is associated with high-grade astrocytic gliomas.
Li H; Wang Q; Gao F; Zhu F; Wang X; Zhou C; Liu C; Chen Y; Ma C; Sun W; Zhang L
Oncol Rep; 2008 Sep; 20(3):573-9. PubMed ID: 18695908
[TBL] [Abstract][Full Text] [Related]
19. [Expression of fibroblast growth factor receptors (FGFRs) mRNA in human astrocytomas].
Yamada SM; Bruner JM; Berger MS; Morrison RS
No To Shinkei; 1996 Apr; 48(4):363-70. PubMed ID: 8679334
[TBL] [Abstract][Full Text] [Related]
20. MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation.
Conti A; Romeo SG; Cama A; La Torre D; Barresi V; Pezzino G; Tomasello C; Cardali S; Angileri FF; Polito F; Ferlazzo G; Di Giorgio R; Germanò A; Aguennouz M
Tumour Biol; 2016 Oct; 37(10):14035-14048. PubMed ID: 27495233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
